Transepithelial transport across the blood–testis barrier
Open Access
- 1 December 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 156 (6) , R187-R194
Abstract
The blood–testis barrier protects developing germ cells by limiting the entry of xenobiotics into the adluminal compartment. There is strong evidence that the male genital tract can serve as a sanctuary site, an area of the body where tumors or viruses are able to survive treatments because most drugs are unable to reach therapeutic concentrations. Recent work has classified the expression and localization of endogenous transporters in the male genital tract as well as the discovery of a transepithelial transport pathway as the molecular mechanism by which nucleoside analogs may be able to circumvent the blood–testis barrier. Designing drug therapies that utilize transepithelial transport pathways may improve drug disposition to this sanctuary site. Strategies that improve disposition into the male genital tract could reduce the rate of testicular relapse, decrease viral load in semen, and improve therapeutic strategies for male fertility.Keywords
This publication has 76 references indexed in Scilit:
- Membrane Transporters for Sulfated Steroids in the Human Testis - Cellular Localization, Expression Pattern and Functional AnalysisPLOS ONE, 2013
- Environmental exposure to arsenic may reduce human semen quality: associations derived from a Chinese cross-sectional studyEnvironmental Health, 2012
- OATPs, OATs and OCTs: the organic anion and cation transporters of theSLCOandSLC22Agene superfamiliesBritish Journal of Pharmacology, 2012
- The Blood-Testis Barrier and Its Implications for Male ContraceptionPharmacological Reviews, 2012
- Emerging role for drug transporters at the blood–testis barrierTrends in Pharmacological Sciences, 2011
- Adjudin-mediated Sertoli–germ cell junction disassembly affects Sertoli cell barrier function in vitro and in vivoThe International Journal of Biochemistry & Cell Biology, 2010
- HIV infection of the male genital tract – consequences for sexual transmission and reproductionInternational Journal of Andrology, 2010
- Drug transporter, P-glycoprotein (MDR1), is an integrated component of the mammalian blood–testis barrierThe International Journal of Biochemistry & Cell Biology, 2009
- Oral administration of the GnRH antagonist acyline, in a GIPET®-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamicsCancer Chemotherapy and Pharmacology, 2009
- MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial CellsExperimental Biology and Medicine, 2008